From this study, we can conclude that the use of clone A7H6R for the screening of tumors with an NTRK1 - 3-rearrangement in mesenchymal neoplasms can lead to less false positive stains and eventually to less negative and costly reflex testing in mesenchymal tumors. This evidence concerns the gene NTRK1 and mesenchymal cell neoplasm.